Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
Holding BOLT?
Track your performance easily

Bolt Biotherapeutics (BOLT) Income Statement

204 Followers

Bolt Biotherapeutics Income Statement

Last quarter (Q2 2024), Bolt Biotherapeutics's total revenue was $1.27M, a decrease of -11.03% from the same quarter last year. In Q2, Bolt Biotherapeutics's net income was $-21.20M. See Bolt Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 11.17M$ 7.88M$ 5.73M$ 1.26M$ 231.00K$ 215.00K
Cost of Revenue
------
Gross Profit
$ 11.17M$ 7.88M$ 5.73M$ 1.26M--
Operating Expense
$ 88.80M$ 84.07M$ 96.05M$ 94.05M$ 49.41M$ 31.18M
Operating Income
$ -77.64M$ -76.20M$ -90.32M$ -92.79M$ -49.18M$ -30.97M
Net Non Operating Interest Income Expense
-$ -7.00M$ -2.22M-$ 199.00K$ 524.00K
Other Income Expense
$ -11.47M$ -7.00M$ -2.22M$ 5.80M$ -11.74M$ -42.00K
Pretax Income
$ -66.17M$ -69.20M$ -88.10M$ -98.59M$ -60.73M$ -30.49M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -66.17M$ -69.20M$ -88.10M$ -98.59M$ -60.73M$ -30.49M
Basic EPS
$ -1.74$ -1.83$ -2.36$ -2.97$ -1.91$ -3.23
Diluted EPS
$ -1.74$ -1.83$ -2.36$ -2.97$ -1.91$ -3.23
Basic Average Shares
$ 152.01M$ 37.81M$ 37.36M$ 33.20M$ 31.85M$ 9.42M
Diluted Average Shares
$ 152.01M$ 37.81M$ 37.36M-$ 31.85M$ 9.42M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 88.80M$ 84.07M$ 96.05M$ 94.05M$ 49.41M$ 31.18M
Net Income From Continuing And Discontinued Operation
$ -66.17M$ -69.20M$ -88.10M$ -98.59M$ -60.73M$ -30.49M
Normalized Income
$ -42.26M$ -54.67M-$ -77.89M$ -48.98M$ -30.45M
Interest Expense
------
EBIT
$ -69.95M$ -76.20M$ -90.32M$ -98.59M$ -49.18M$ -30.97M
EBITDA
$ -66.55M$ -74.34M$ -88.66M$ -92.27M$ -48.57M$ -30.63M
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis